The Pharma Letter - Pharmaceuticals - MedicinesPHARMACEUTICALS covers patent-protected prescription medicines, with news relating to drugmakers, their financial  performance, licensing, research and merger & acquisition activities. This also reports on health care markets, patent developments,  legislation, product approvals and delays around the globe, backed by a massive archive from which developments in all these areas can be tracked.

Latest Pharma Letter Articles

Pharmaceutical

features_upload

Silence Thera receives takeover approach from unnamed drug firm

7 September 2010

UK-based drug developer Silence Therapeutics (AIM: SLN) saw its share price skyrocket 76% to

European and international experts prepare for the evaluation of future nano-medicines

7 September 2010

The European Medicines Agency (EMEA) hosted the first international scientific workshop on

Bausch & Lomb moves to acquire Miochol-E from Novartis as required by US competition authority

7 September 2010

In order to comply with US anti-trust requirements imposed by the Federal Trade Commission

Pharma should make “the private public” to boost research, industry execs conclude

7 September 2010

Last week, executives from companies including AstraZeneca, GlaxoSmithKline, Johnson & Johnson,

Israel relaxes restrictions on medical marijuana; scientists develop new HIV/AIDS treatment

7 September 2010

Israel’s Ministry of Health has authorized doctors from five of the country’s different hospitals

Swiss firm Helsinn opens new $16.7 million R&D center in Ireland

7 September 2010

Independent Swiss pharmaceutical group Helsinn last week officially opened its new “center